CLOBETASOL 0.05%w/w IP + SALICYLIC ACID 3.00%w/w IP + UREA 10.00%w/w IP + LACTIC...

A topical ointment that provides relief from inflammatory manifestations of skin conditions such as psoriasis, atopic dermatitis, and eczema. Exfoliates and softens the outer layers of dead skin cells and decreases the thickness of psoriatic plaques. Lessens intercellular cohesion between corneocytes by dissolving the intercellular cement material and reducing the pH of the stratum corneum. (Arnd Jacobi, 2015) A potential attractive agent due to its anti-inflammatory, antipruritic, vasoconstrictive, and immune-modulating properties. (Jacques Decroix, 2004) Blocks the production of certain chemical messengers which is responsible for making the skin red, swollen, and itchy. Exhibits keratolytic, moisturizing, desquamating, and antipruritic effects. (Raab, 1989) A safe and effective keratolytic agent that breaks down keratin filaments and softens the skin. (Arif, 2015) A beneficial approach in treating psoriasis that reduces scale and softens lesions. Plays an important role in the preservation of skin hydration and integrity. (Celleno, 2018) Offers a greater reduction in flakiness, roughness, redness, and cracking in ichthyosis patients. (Jaime Piquero-Casals, 2021) Ameliorates water retention capacity and decreases transepidermal water loss, pruritus, desquamation, and hyperkeratosis in patients with psoriasis. (Jaime Piquero-Casals, 2021)